Bernard Lauwerys

5.8k total citations
84 papers, 2.5k citations indexed

About

Bernard Lauwerys is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bernard Lauwerys has authored 84 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Rheumatology, 38 papers in Immunology and 20 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bernard Lauwerys's work include Systemic Lupus Erythematosus Research (35 papers), Rheumatoid Arthritis Research and Therapies (31 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). Bernard Lauwerys is often cited by papers focused on Systemic Lupus Erythematosus Research (35 papers), Rheumatoid Arthritis Research and Therapies (31 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). Bernard Lauwerys collaborates with scholars based in Belgium, United States and United Kingdom. Bernard Lauwerys's co-authors include Frédéric Houssiau, Jean‐Christophe Renauld, Frédéric Houssiau, A. Nzeusseu Toukap, Patrick Durez, Christine Galant, Ivan Théate, Anne‐Lise Maudoux, Farah Tamirou and Rik Lories and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Bernard Lauwerys

77 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Lauwerys Belgium 29 1.4k 1.3k 454 327 317 84 2.5k
Josep Ordi‐Ros Spain 30 1.4k 0.9× 940 0.7× 738 1.6× 154 0.5× 277 0.9× 69 2.6k
Wayel H. Abdulahad Netherlands 39 1.3k 0.9× 1.9k 1.5× 667 1.5× 430 1.3× 137 0.4× 128 4.3k
Akito Tsutsumi Japan 28 1.5k 1.0× 1.2k 1.0× 365 0.8× 217 0.7× 512 1.6× 101 2.6k
Robert Biesen Germany 23 968 0.7× 972 0.8× 305 0.7× 198 0.6× 234 0.7× 62 1.7k
Birgitta Gullstrand Sweden 27 954 0.7× 1.7k 1.3× 706 1.6× 147 0.4× 192 0.6× 57 2.4k
Fabien B. Vincent Australia 19 788 0.5× 1.2k 0.9× 236 0.5× 198 0.6× 282 0.9× 34 1.8k
H Chwalińska-Sadowska Poland 14 1.3k 0.9× 992 0.8× 187 0.4× 191 0.6× 257 0.8× 29 1.9k
Jörn Drappa United States 21 1.6k 1.1× 2.1k 1.7× 673 1.5× 469 1.4× 667 2.1× 31 3.3k
J E Salmon United States 17 741 0.5× 1.1k 0.8× 395 0.9× 176 0.5× 720 2.3× 28 2.0k
Raymond E. Felgar United States 22 813 0.6× 1.4k 1.1× 240 0.5× 486 1.5× 682 2.2× 38 2.8k

Countries citing papers authored by Bernard Lauwerys

Since Specialization
Citations

This map shows the geographic impact of Bernard Lauwerys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Lauwerys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Lauwerys more than expected).

Fields of papers citing papers by Bernard Lauwerys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Lauwerys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Lauwerys. The network helps show where Bernard Lauwerys may publish in the future.

Co-authorship network of co-authors of Bernard Lauwerys

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Lauwerys. A scholar is included among the top collaborators of Bernard Lauwerys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Lauwerys. Bernard Lauwerys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saito, Shigeru, Angela E. Scheuerle, Shinya YASUDA, et al.. (2025). Pharmacovigilance Pregnancy Data in a Population of Japanese Patients With Chronic Inflammatory Disease Exposed to Certolizumab Pegol. International Journal of Rheumatic Diseases. 28(1). e70048–e70048. 1 indexed citations
2.
Bidgood, Sarah, David Kallenberg, Anthony Turner, et al.. (2024). POS0722 PURIFIED MONOCLONAL RHEUMATOID FACTORS BIND FC CONTAINING TNF INHIBITORS IN VITRO BUT NOT THE FC-FREE TNF INHIBITOR, CERTOLIZUMAB PEGOL. Annals of the Rheumatic Diseases. 83. 727–728.
3.
Smolen, Josef S, Peter C. Taylor, Yoshiya Tanaka, et al.. (2024). Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis. Lara D. Veeken. 63(11). 3015–3024. 6 indexed citations
4.
5.
Tilman, Gaëlle, Axelle Loriot, Joëlle Marchandise, et al.. (2023). Disease activity drives transcriptomic heterogeneity in early untreated rheumatoid synovitis. Annals of the Rheumatic Diseases. 82(12). 1538–1546. 7 indexed citations
6.
Quartier, Pierre, Lien De Somer, Bernard Lauwerys, et al.. (2023). Patterns and determinants of response to novel therapies in juvenile and adult-onset polyarthritis. Lara D. Veeken. 63(3). 594–607. 4 indexed citations
7.
Nicolaou, Paschalis, Kleitos Sokratous, Christine Galant, et al.. (2020). Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches. Arthritis Research & Therapy. 22(1). 107–107. 6 indexed citations
8.
Lauwerys, Bernard, Patrick Durez, Vincent Geenen, et al.. (2020). THU0032 MODIFIED PEPTIDES AS A NOVEL IMMUNOTHERAPY FOR RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 79. 229–229. 1 indexed citations
9.
Brogan, Paul, Michaël Hofer, Jasmin Kuemmerle‐Deschner, et al.. (2019). Rapid and Sustained Long‐Term Efficacy and Safety of Canakinumab in Patients With Cryopyrin‐Associated Periodic Syndrome Ages Five Years and Younger. Arthritis & Rheumatology. 71(11). 1955–1963. 32 indexed citations
10.
Groof, Aurélie De, Patrice Hémon, Olivier Mignen, et al.. (2017). Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus. Clinical Reviews in Allergy & Immunology. 53(2). 181–197. 21 indexed citations
11.
Lauwerys, Bernard, et al.. (2014). sIL7R concentrations in the serum reflect disease activity in the lupus kidney. Lupus Science & Medicine. 1(1). e000036–e000036. 10 indexed citations
12.
Henrohn, Dan, Fredrik Rorsman, Johan Lennartsson, et al.. (2009). Lack of evidence of stimulatory autoantibodies to platelet‐derived growth factor receptor in patients with systemic sclerosis. Arthritis & Rheumatism. 60(4). 1137–1144. 72 indexed citations
13.
Badot, Valérie, Christine Galant, A. Nzeusseu Toukap, et al.. (2009). Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis. Arthritis Research & Therapy. 11(2). R57–R57. 76 indexed citations
14.
Gutierrez-Roelens, Ilse & Bernard Lauwerys. (2008). Genetic Susceptibility to Autoimmune Disorders: Clues from Gene Association and Gene Expression Studies. Current Molecular Medicine. 8(6). 551–561. 19 indexed citations
15.
16.
Durez, Patrick, Jacques Malghem, Bernard Lauwerys, et al.. (2006). A prospective one year randomized comparative clinical and MRI study of the effects of methotrexate (MTX) alone or in combination with infliximab (IFX) or intravenous (IV) pulse methylprednisolone (MP) in early rheumatoid arthritis (RA). Annals of the Rheumatic Diseases. 65. 54–55. 8 indexed citations
17.
Durez, Patrick, A. Nzeusseu Toukap, Bernard Lauwerys, et al.. (2004). A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment. Annals of the Rheumatic Diseases. 63(9). 1069–1074. 37 indexed citations
18.
Lauwerys, Bernard, et al.. (2000). Cytokine Production and Killer Activity of NK/T-NK Cells Derived with IL-2, IL-15, or the Combination of IL-12 and IL-18. The Journal of Immunology. 165(4). 1847–1853. 172 indexed citations
19.
Lauwerys, Bernard, Jean‐Christophe Renauld, & Frédéric Houssiau. (1999). SYNERGISTIC PROLIFERATION AND ACTIVATION OF NATURAL KILLER CELLS BY INTERLEUKIN 12 AND INTERLEUKIN 18. Cytokine. 11(11). 822–830. 121 indexed citations
20.
Houssiau, Frédéric & Bernard Lauwerys. (1998). Immunotherapeutic Approaches of Rheumatic Disorders. Acta Clinica Belgica. 53(3). 155–161. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josep Ordi‐Ros Breakdown of academic impact, for papers by Wayel H. Abdulahad Breakdown of academic impact, for papers by Akito Tsutsumi Breakdown of academic impact, for papers by Robert Biesen Breakdown of academic impact, for papers by Birgitta Gullstrand Breakdown of academic impact, for papers by Fabien B. Vincent Breakdown of academic impact, for papers by H Chwalińska-Sadowska Breakdown of academic impact, for papers by Jörn Drappa Breakdown of academic impact, for papers by J E Salmon Breakdown of academic impact, for papers by Raymond E. Felgar
Rankless by CCL
2026